Associated Papers
The SeqSplice multiplexed minigene splicing assay for characterization and quantitation of variant-induced BRCA1 and BRCA2 splice isoforms.
Canson DM et al.
Genome Research, 2025
40769711 (PubMed )
Supplement: Supplemental_Table_S1.xlsx › S1.splicing_results_summary
Precision screening facilitates clinical classification of BRCA2-PALB2 binding variants with benign and pathogenic functional effects.
Bose M et al.
The Journal of Clinical Investigation, 2025
40232841 (PubMed )
Supplement: jci-135-181879-s033.xlsx › Supplementary_Table_4
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers.
Shah JB et al.
Nature Communications, 2022
36344544 (PubMed )
Supplement: 41467_2022_34523_MOESM14_ESM.xlsx › TCGABreast_HR-WT
Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2.
Aljarf R et al.
Scientific Reports, 2022
35729312 (PubMed )
Supplement: 41598_2022_13508_MOESM2_ESM.xlsx › Sheet1
Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations.
Lal A et al.
Bmc Medical Genomics, 2019
31182087 (PubMed )
Supplement: 12920_2019_545_MOESM10_ESM.xlsx › methylation
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.
Kan Z et al.
Nature Communications, 2018
29713003 (PubMed )
Supplement: 41467_2018_4129_MOESM4_ESM.xlsx › S1
Select a paper to view details